Corventis

By Aditi Pai June 30, 2014
In the first half of 2014, digital health funding reached $2.3 billion, according to a report from accelerator Rock Health. The report included data from 143 digital health companies that have raised over $2 million during the past six months. Funding in the first two quarters of 2014 surpassed total funding for all of 2013, which was $1.97 billion. Deal growth was driven by early-stage companies...
By Jonah Comstock June 10, 2014
Researcher Ronen Polsky holds the prototype sensor. Sandia National Laboratories, a division of Lockheed Martin, has developed a potentially wearable hydration and electrolyte sensor that uses tiny needles to sample a negligible amount of interstitial fluid -- the liquid between cells. The study was published this month in the journal Advanced Healthcare Materials. “We’re proposing a minimally...
By Jonah Comstock June 5, 2014
As we head into the halfway point of 2014, it's already clear that the trend of mobile and digital health acquisitions is up. Just five months into the year, MobiHealthNews has tracked 16 mergers, acquisitions, asset buys and majority stake acquisitions -- just one less transaction than we tracked during the whole of 2013. While many of the buys were medical software acquisitions of various kinds...
By Brian Dolan May 21, 2014
In 2009 when Corventis first unveiled its technology, its main offering was an innovative fluid sensor, which was part of the array of sensors embedded in its peel-and-stick patch that was eventually named PiiX. One of the grave symptoms for heart failure patients is fluid collection in the heart -- a symptom that most remote monitoring companies track by simply keeping tabs on a patient's weight...
By Brian Dolan May 20, 2014
Medical device giant Medtronic is in the final stages of acquiring peel-and-stick medical sensor company Corventis for north of $150 million, MobiHealthNews has learned. While neither company has publicly commented on the deal, it is expected to be officially announced some time in the next few weeks. (Update: I've heard conflicting reports from sources on the price of the deal since publishing...
By MHN Staff May 24, 2012
Photo Credit: Paul Savage Photography By Padma Nagappan Misfit Wearables, the wearable computing start-up with $7.6 million in funding, founded by Sonny Vu and Sridhar Iyengar, co-founders of AgaMatrix, and former Apple CEO John Sculley, has kept mum on what it's developing. During his presentation at the WLSA Convergence Summit in San Diego this week, Vu didn't reveal any secrets, but rather...
By Brian Dolan February 7, 2012
CardioComm ECG Monitor CardioComm Solutions and TZ Medical inked a device integration and distribution deal that brings the pair into the the mobile cardiac telemetry (MCT) electrocardiographic (ECG) and arrhythmia management market. CardioComm will integrate TZM's Aera CT MCT monitor into its GEMS software to create a new offering called GEMS Aera CT. It will be an extension of CardioComm's...
By Brian Dolan May 25, 2011
Gemalto-owned Cinterion has inked a deal with TZ Medical to embed a cellular wireless chip into the medical device company's heart arrhythmia monitoring device, Aera-CT, which the companies expect to launch in North America during the third quarter. TZ explains that the device can monitor patients for up to 28 days and also enables care providers to communicate with patients via the device. The...
By Brian Dolan November 3, 2010
Big news for anyone concerned about reimbursement issues for wireless health: CardioNet, which leverages wireless technology to diagnose and monitor cardiac arrhythmias, announced this week that the Centers for Medicare and Medicaid Services (CMS) has established a national rate for the technical component of mobile cardiovascular telemetry (MCOT). CardioNet said that the rate is approximately $...
By Brian Dolan October 12, 2010
AT&T has inked a deal with eCardio Diagnostics to provide wireless connectivity to the arrhythmia monitoring company's near real-time cardiac monitoring devices. eCardio’s monitoring devices enable heart patients to recover at home rather than spend additional time in the hospital and aim to help reduce re-admissions among heart patients. According to the companies' release, "eCardio has...